Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.08.029Source: DataRank Database

Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials is a research paper published in Journal of Allergy and Clinical Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 157 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access157 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 13.48)OA: hybridTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (40)

Melanie Wong ORCID,Daniel Rayner ORCID,Gordon Guyatt ORCID,Juan Pablo Díaz Martinez ORCID,Renata Ceccacci

Live enrichment

PubMed:37678577 OpenAlex:https://openalex.org/W4386530720

Foundation of the American College of Allergy, Asthma & Immunology

American Academy of Allergy Asthma and Immunology

FWCI

13.48

Citation Percentile

1.0%

Influential Citations

Citation Trend

2023

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttp://www.jacionline.org/article/S0091674923011120/pdf

HYBRIDhttp://www.jacionline.org/article/S0091674923011120/pdf

publisherhttp://www.jacionline.org/article/S0091674923011120/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0091674923011120?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674923011120?httpAccept=text/plain

Fields of Study

Dermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisAllergic Rhinitis and SensitizationMedicineHumansDermatitis, AtopicQuality of LifeRandomized Controlled Trials as TopicEczemaAsthmaTreatment OutcomePyrimidinesSulfonamides

MeSH Terms

Network Meta-AnalysisAsthmaDermatitis, AtopicEczemaHumansPyrimidinesQuality of LifeSulfonamidesRandomized Controlled Trials as TopicTreatment Outcome

Keywords

Atopic dermatitisMedicineMeta-analysisRandomized controlled trialDermatologyInternal medicineAtopic Dermatitis (Eczema)Janus Kinase (Jak) Inhibitors (Upadacitinib, Abrocitinib, Baricitinib), Patient-important Outcomes And Adverse Events Or Adverse Reactions, Disease Severity, Itch, Sleep, Itch And Sleep Disturbance Quality Of LifeNetwork Meta-analysis (Comparative Effectiveness, Multiple Treatment Comparison)Systemic Treatments And Phototherapy (Light Therapy, Immunosuppressants, Immunomodulators, Dmards, Cyclosporine, Methotrexate, Azathioprine, Mycophenolate, Cortiosteroids, Narrow-band Uvb), Biologics (Dupilumab, Lebrikizumab, Tralokinumab, Nemolizumab)

Sustainable Development Goals

SDG 0: Good health and well-being